Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

NCT00002504 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Precancerous/Nonmalignant Condition
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: recombinant interferon alfa

Sponsor

Hoag Memorial Hospital Presbyterian

Collaborators

[object Object]